Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
- DOI
- 10.1002/ejhf.3673
- Published
- 2025 Jun
- Container
- European journal of heart failure
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ejhf.3673,
title = {Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).},
author = {Chioncel O and Mebazaa A and Farmakis D and Abdelhamid M and Lund LH and Harjola VP and Anker S and Filippatos G and Ben-Gal T and Damman K and Skouri H and Antohi L and Collins SP and Adamo M and Miro O and Hill L and Parissis J and Moura B and Mueller C and Jankowska E and Lopatin Y and Dunlap M and Volterrani M and Fudim M and Flammer AJ and Mullens W and Pang PS and Tica O and Ponikowski P and Ristic A and Butler J and Savarese G and Cicoira M and Thum T and Bayes Genis A and Polyzogopoulou E and Seferovic P and Yilmaz MB and Rosano G and Coats AJS and Metra M},
year = {2025},
journal = {European journal of heart failure},
doi = {10.1002/ejhf.3673},
url = {https://doi.org/10.1002/ejhf.3673}
}RIS
TY - JOUR TI - Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). AU - Chioncel O AU - Mebazaa A AU - Farmakis D AU - Abdelhamid M AU - Lund LH AU - Harjola VP AU - Anker S AU - Filippatos G AU - Ben-Gal T AU - Damman K AU - Skouri H AU - Antohi L AU - Collins SP AU - Adamo M AU - Miro O AU - Hill L AU - Parissis J AU - Moura B AU - Mueller C AU - Jankowska E AU - Lopatin Y AU - Dunlap M AU - Volterrani M AU - Fudim M AU - Flammer AJ AU - Mullens W AU - Pang PS AU - Tica O AU - Ponikowski P AU - Ristic A AU - Butler J AU - Savarese G AU - Cicoira M AU - Thum T AU - Bayes Genis A AU - Polyzogopoulou E AU - Seferovic P AU - Yilmaz MB AU - Rosano G AU - Coats AJS AU - Metra M PY - 2025 JO - European journal of heart failure DO - 10.1002/ejhf.3673 UR - https://doi.org/10.1002/ejhf.3673 ER -
APA
O, C., A, M., D, F., M, A., LH, L., VP, H., S, A., G, F., T, B., K, D., H, S., L, A., SP, C., M, A., O, M., L, H., J, P., B, M., C, M., E, J., Y, L., M, D., M, V., M, F., AJ, F., W, M., PS, P., O, T., P, P., A, R., J, B., G, S., M, C., T, T., A, B. G., E, P., P, S., MB, Y., G, R., AJS, C., & M, M. (2025). Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).. European journal of heart failure. https://doi.org/10.1002/ejhf.3673
Source records
- pubmed · retrieved 2026-09-26T13:43:15.975Z